Andre Machado, MD
Neurological Surgery · Cleveland, OHNPI 1346306073
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,813 of the $31,252 with a category attached, or 73.0%. Abbott accounts for 60.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $16,592 and has fallen 78.3% since, to $3,600 in 2025.
Across 58 payments — averaging $538.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$19K
- Novo Nordisk$6K
- Clearpoint Neuro, Inc.$3K
- Boston Scientific$2K
- Insightec,inc$2K
- GSK$182
- plus $261 from 3 others
Across 25 payments — averaging $4819.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$120K
What the payments were for
- Consulting fees$22,81373%
- Speaking & faculty fees$1,6505%
- Travel & lodging$4,86616%
- Food & beverage$1,9236%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 28 | $18,830 |
| Novo Nordisk | 2 | $6,000 |
| Clearpoint Neuro, Inc. | 10 | $2,829 |
| Boston Scientific | 1 | $1,650 |
| Insightec,inc | 1 | $1,500 |
| GSK | 12 | $182 |
| Stryker | 2 | $154 |
| Boehringer Ingelheim | 1 | $80 |
| Medtronic | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$17,187
- CLEARPOINT$2,676
- VERCISE$1,650
- Neuromodulation Dspsbls and Accs$1,200
- N/A$139
How this compares
$31,252 in reported general payments places this provider in the 80th percentile of 301 neurological surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurological surgery in Cleveland
- Abdi MohitCleveland$884K
- Mark BainCleveland$242K
- Pablo RecinosCleveland$211K
- Michael SteinmetzCleveland$168K
- Josue Avecillas ChasinCleveland$144K
- Gene BarnettCleveland$135K
- Prakash KotagalCleveland$82K
- Ajit KrishnaneyCleveland$76K
- Gabriel SmithCleveland$72K
- Peter RasmussenCleveland$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.